TECTONIC THERAPEUTIC, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
TECTONIC THERAPEUTIC, INC. (TECX) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$47.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$22.29M.
- TECTONIC THERAPEUTIC, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$25.24M.
- TECTONIC THERAPEUTIC, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$19.23M.
- TECTONIC THERAPEUTIC, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$19.04M.
- TECTONIC THERAPEUTIC, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$74.15M.
- TECTONIC THERAPEUTIC, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$57.98M.
- TECTONIC THERAPEUTIC, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$42.82M.
- TECTONIC THERAPEUTIC, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$105.89M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$22.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$47.53M 10-Q · filed 2026-08-06 | -$66.75M derived: sum of 3 quarters · filed 2026-08-06 | -$85.79M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$25.24M 10-Q · filed 2026-05-07 | -$44.47M derived: sum of 2 quarters · filed 2026-05-07 | -$63.50M derived: sum of 3 quarters · filed 2026-05-07 | -$83.49M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$19.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$38.26M derived: sum of 2 quarters · filed 2026-02-26 | -$58.24M derived: sum of 3 quarters · filed 2026-08-06 | -$74.15M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$19.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$39.02M derived: sum of 2 quarters · filed 2026-08-06 | -$54.92M 10-Q · filed 2025-11-06 | -$67.30M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$19.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$35.89M 10-Q · filed 2026-08-06 | -$48.26M derived: sum of 3 quarters · filed 2026-08-06 | -$65.98M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$15.91M 10-Q · filed 2026-05-07 | -$28.28M derived: sum of 2 quarters · filed 2026-05-07 | -$46.00M derived: sum of 3 quarters · filed 2026-05-07 | -$58.67M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$12.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$30.09M derived: sum of 2 quarters · filed 2026-02-26 | -$42.76M derived: sum of 3 quarters · filed 2026-02-26 | -$57.98M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$17.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$30.39M derived: sum of 2 quarters · filed 2025-11-06 | -$45.61M 10-Q · filed 2025-11-06 | -$53.48M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$12.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$27.89M 10-Q · filed 2025-08-07 | -$35.76M derived: sum of 3 quarters · filed 2025-08-07 | -$45.81M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$15.22M 10-Q · filed 2025-05-08 | -$6.81M 10-Q · filed 2024-05-09 | -$23.09M derived: sum of 2 quarters · filed 2025-05-08 | -$33.14M derived: sum of 3 quarters · filed 2025-05-08 | -$33.09M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | -$7.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$17.92M derived: sum of 2 quarters · filed 2025-03-20 | -$17.87M derived: sum of 3 quarters · filed 2025-03-20 | -$42.82M 10-K · filed 2025-03-20 | $12.16M 10-K · filed 2024-03-14 | |||
| 2023-09-30 | -$10.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$10.00M derived: sum of 2 quarters · filed 2024-11-12 | -$34.95M 10-Q · filed 2024-11-12 | $20.94M 10-Q · filed 2023-11-09 | -$59.99M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$24.90M 10-Q · filed 2024-08-14 | $42.52M 10-Q · filed 2023-08-10 | -$49.93M derived: sum of 3 quarters · filed 2024-08-14 | -$72.90M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$24.96M 10-Q · filed 2024-05-09 | -$49.99M derived: sum of 2 quarters · filed 2024-05-09 | -$72.96M derived: sum of 3 quarters · filed 2024-05-09 | -$101.01M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$25.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$48.00M derived: sum of 2 quarters · filed 2024-03-14 | -$76.06M derived: sum of 3 quarters · filed 2024-03-14 | -$105.89M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | -$22.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$51.02M derived: sum of 2 quarters · filed 2023-11-09 | -$80.86M 10-Q · filed 2023-11-09 | -$109.08M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$28.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$57.89M 10-Q · filed 2023-08-10 | -$86.11M derived: sum of 3 quarters · filed 2023-08-10 | -$118.73M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$29.83M 10-Q · filed 2023-05-11 | -$58.06M derived: sum of 2 quarters · filed 2023-05-11 | -$90.67M derived: sum of 3 quarters · filed 2023-05-11 | -$122.06M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$28.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$60.84M derived: sum of 2 quarters · filed 2023-03-23 | -$92.23M derived: sum of 3 quarters · filed 2023-03-23 | -$119.13M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | -$32.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$64.00M derived: sum of 2 quarters · filed 2022-11-08 | -$90.90M 10-Q · filed 2022-11-08 | -$119.03M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$31.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$58.29M 10-Q · filed 2022-08-09 | -$86.42M derived: sum of 3 quarters · filed 2022-08-09 | -$123.20M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$26.90M 10-Q · filed 2022-05-10 | -$55.03M derived: sum of 2 quarters · filed 2022-05-10 | -$91.81M derived: sum of 3 quarters · filed 2022-05-10 | -$120.64M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$28.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$64.91M derived: sum of 2 quarters · filed 2022-03-17 | -$93.74M derived: sum of 3 quarters · filed 2022-03-17 | -$119.71M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | -$36.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$65.61M derived: sum of 2 quarters · filed 2021-11-04 | -$91.58M 10-Q · filed 2021-11-04 | -$114.24M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$28.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$54.80M 10-Q · filed 2021-08-05 | -$77.46M derived: sum of 3 quarters · filed 2021-08-05 | -$94.61M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$25.97M 10-Q · filed 2021-05-13 | -$48.63M derived: sum of 2 quarters · filed 2021-05-13 | -$65.78M derived: sum of 3 quarters · filed 2021-05-13 | -$81.83M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$22.66M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$39.81M derived: sum of 2 quarters · filed 2021-03-18 | -$55.86M derived: sum of 3 quarters · filed 2021-03-18 | -$72.97M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | -$17.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$33.20M derived: sum of 2 quarters · filed 2020-11-05 | -$50.30M 10-Q · filed 2020-11-05 | -$66.32M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$16.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$33.16M 10-Q · filed 2020-08-06 | -$49.18M derived: sum of 3 quarters · filed 2020-08-06 | -$60.77M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$17.10M 10-Q · filed 2020-05-07 | -$33.12M derived: sum of 2 quarters · filed 2020-05-07 | -$44.72M derived: sum of 3 quarters · filed 2020-05-07 | -$55.22M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$16.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$27.61M derived: sum of 2 quarters · filed 2020-03-16 | -$38.12M derived: sum of 3 quarters · filed 2020-03-16 | -$46.36M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | -$11.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$22.10M derived: sum of 2 quarters · filed 2019-11-07 | -$30.34M 10-Q · filed 2019-11-07 | -$37.94M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$10.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$18.75M 10-Q · filed 2019-08-08 | -$26.34M derived: sum of 3 quarters · filed 2019-08-08 | -$32.79M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$8.24M 10-Q · filed 2019-05-13 | -$15.84M derived: sum of 2 quarters · filed 2019-05-13 | -$22.28M derived: sum of 3 quarters · filed 2019-05-13 | |||||
| 2017-12-31 | -$7.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | -$14.04M derived: sum of 2 quarters · filed 2019-03-25 | -$18.65M 10-K · filed 2019-03-25 | |||||
| 2017-09-30 | -$6.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$11.05M 10-Q · filed 2018-11-13 | ||||||
| 2017-06-30 | -$4.61M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |